129 related articles for article (PubMed ID: 23345583)
1. Seropositivity rates for measles, mumps, and rubella IgG and costs associated with testing and revaccination.
Shirts BH; Welch RJ; Couturier MR
Clin Vaccine Immunol; 2013 Mar; 20(3):443-5. PubMed ID: 23345583
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility to measles, mumps, and rubella in 5-year-old children in Flanders, Belgium.
Leuridan E; Maertens K; Wautier M; Hutse V; Theeten H
Eur J Pediatr; 2015 Jul; 174(7):925-32. PubMed ID: 25579232
[TBL] [Abstract][Full Text] [Related]
3. Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection.
Díaz Ortega JL; Castaneda D; Arellano Quintanilla DM; Martínez D; Trumbo SP; Fernández de Castro J
Vaccine; 2017 May; 35(23):3116-3122. PubMed ID: 28457672
[TBL] [Abstract][Full Text] [Related]
4. High seroprevalence of varicella, measles, mumps, rubella and pertussis antibodies in first-grade medical students.
Socan M; Berginc N
Wien Klin Wochenschr; 2008; 120(13-14):422-6. PubMed ID: 18726668
[TBL] [Abstract][Full Text] [Related]
5. Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save?
Alp E; Cevahir F; Gökahmetoglu S; Demiraslan H; Doganay M
J Infect Public Health; 2012 Apr; 5(2):127-32. PubMed ID: 22541258
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
Sultana R; Rahman MM; Hassan Z; Hassan MS
Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of antibodies against measles, mumps and rubella in the childhood population in Singapore, 2008-2010.
Ang LW; Lai FY; Tey SH; Cutter J; James L; Goh KT
Epidemiol Infect; 2013 Aug; 141(8):1721-30. PubMed ID: 22999024
[TBL] [Abstract][Full Text] [Related]
8. Measles-mumps-rubella revaccination; 18 months vs. 4-6 years of age: potential impacts of schedule changes.
Saffar MJ; Fathpour GR; Parsaei MR; Ajami A; Khalilian AR; Shojaei J; Saffar H
J Trop Pediatr; 2011 Oct; 57(5):347-51. PubMed ID: 21078605
[TBL] [Abstract][Full Text] [Related]
9. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.
Wang Z; Yan R; He H; Li Q; Chen G; Yang S; Chen E
PLoS One; 2014; 9(2):e89361. PubMed ID: 24586717
[TBL] [Abstract][Full Text] [Related]
10. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia.
Jaber SM
Saudi Med J; 2006 Jan; 27(1):63-9. PubMed ID: 16432596
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.
Gohil DJ; Kothari ST; Chaudhari AB; Gunale BK; Kulkarni PS; Deshmukh RA; Chowdhary AS
Viral Immunol; 2016 Apr; 29(3):159-63. PubMed ID: 26910764
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of antibodies to measles, mumps, and rubella, and serologic responses after vaccination among human immunodeficiency virus (HIV)-1 infected adults in Northern Thailand.
Chaiwarith R; Praparattanapan J; Nuket K; Kotarathitithum W; Supparatpinyo K
BMC Infect Dis; 2016 Apr; 16():190. PubMed ID: 27138005
[TBL] [Abstract][Full Text] [Related]
13. Rubella, rubeola, and mumps in pregnant women: susceptibilities and strategies for testing and vaccinating.
Haas DM; Flowers CA; Congdon CL
Obstet Gynecol; 2005 Aug; 106(2):295-300. PubMed ID: 16055578
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age.
Ceyhan M; Kanra G; Erdem G; Kanra B
Vaccine; 2001 Aug; 19(31):4473-8. PubMed ID: 11483273
[TBL] [Abstract][Full Text] [Related]
15. Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in Germany.
Schwarze-Zander C; Draenert R; Lehmann C; Stecher M; Boesecke C; Sammet S; Wasmuth JC; Seybold U; Gillor D; Wieland U; Kümmerle T; Strassburg CP; Mankertz A; Eis-Hübinger AM; Jäger G; Fätkenheuer G; Bogner JR; Rockstroh JK; Vehreschild JJ
Epidemiol Infect; 2017 Jan; 145(2):236-244. PubMed ID: 27780480
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness of prevaccination screening of health care workers for immunity to measles, rubella and mumps.
Ferson MJ; Robertson PW; Whybin LR
Med J Aust; 1994 Apr; 160(8):478-82. PubMed ID: 8170422
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey.
Amela C; Pachón I; de Ory F
Eur J Epidemiol; 2003; 18(1):71-9. PubMed ID: 12705626
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalences of Specific IgG Antibodies to Measles, Mumps, and Rubella in Korean Infants.
Cho HK; Lee H; Kim HW; Kim SS; Kang HJ; Kim IT; Kim KH
J Korean Med Sci; 2016 Dec; 31(12):1957-1962. PubMed ID: 27822935
[TBL] [Abstract][Full Text] [Related]
19. Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses.
Nicoara C; Zäch K; Trachsel D; Germann D; Matter L
Clin Diagn Lab Immunol; 1999 Nov; 6(6):868-71. PubMed ID: 10548578
[TBL] [Abstract][Full Text] [Related]
20. Low mumps antibody levels induced by mumps-measles-rubella vaccinations in type 1 diabetic children.
Hiltunen M; Hyöty H; Leinikki P; Akerblom HK; Tuomilehto J; Vesikari T
Diabet Med; 1994 Dec; 11(10):942-6. PubMed ID: 7895458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
